Welcome to Key Biologics
Key Biologics' goal and our clients' goals are the same: to advance life science from discovery, through R&D, and into curing disease. We provide unique and high-value human-derived biomaterials (cells and blood components) derived from human blood, umbilical cord, and in the near future, bone marrow. In that effort, Key Biologics supports the work of researchers worldwide at major universities, in early-stage biotech companies, and in large drug companies. Provision of these blood products makes possible first-in-human clinical trials of biological drugs that may one day cure blood disorders such as sickle cell disease and some forms of cancer and vaccines that may one day prevent malaria.
